Načítá se...
The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent
BACKGROUND: Patients with chronic pancreatitis and pancreatic cancer commonly develop exocrine pancreatic insufficiency, and may not be adequately treated with pancreatic enzyme replacement therapy (PERT). AIMS: To estimate the frequency of diagnostic testing for exocrine insufficiency, and appropri...
Uloženo v:
| Vydáno v: | Aliment Pharmacol Ther |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7299155/ https://ncbi.nlm.nih.gov/pubmed/32249970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15698 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|